Corcept医疗

CORT NASDAQ
10.40
+0.04
+0.39%
交易中 15:10 06/17 EDT
开盘
10.40
昨收
10.36
最高
10.47
最低
10.32
成交量
22.30万
成交均量(3M)
73.71万
52周最高
19.56
52周最低
9.14
换手率
0.19%
市值
11.95亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Corcept医疗 CORT股票价格,Corcept医疗股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR). As of December 31, 2016, it had discovered three structurally distinct series of selective cortisol modulators, all of which share mifepristone's affinity for GR but, unlike mifepristone, do not bind to the progesterone receptor. It is conducting two clinical trials of its selective cortisol modulator, CORT125134. One trial is investigating CORT125134 as a treatment for patients with Cushing syndrome. The second trial is investigating the combination of CORT125134 and nab-paclitaxel (Celgene Corporation's Abraxane) to treat patients with solid-tumor cancers.
展开 >

最近浏览

名称
价格
涨跌幅